Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | MVIS | Common Stock | Options Exercise | $0 | +50.3K | +88.94% | $0.00 | 107K | Nov 16, 2023 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | MVIS | Restricted Stock Units | Options Exercise | $0 | -50.3K | -100% | $0.00* | 0 | Nov 16, 2023 | Common Stock | 50.3K | $0.00 | Direct | F2, F3 |
Id | Content |
---|---|
F1 | Vested restricted stock units, or RSUs, were distributed to the Reporting Person, without payment, in shares of common stock on a unit-for-share basis. |
F2 | At vesting, converts into shares of common stock on a unit-for-share basis |
F3 | RSUs granted November 16, 2021 are scheduled to vest as to 10% on March 16, 2022, 30% on November 16, 2022, 30% on November 16, 2023, 20% on November 16, 2024, and the final 10% on November 16, 2025, with each such vesting event subject to the Reporting Person's continued employment with MicroVision on the respective vesting date. |